Millions of doses of ‘pandemic-ending’ HIV jab at risk over Trump’s aid cuts
INTERVIEW: The funding for 2 million people to receive the twice-yearly preventative treatment lenacapavir is ‘receding in the chaos’ of the US president’s decision, the doctor behind the trial of the drug tells Rachel Schraer
The Independent UK ·